cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cel Sci Corp
12 own
15 watching
Current Price
$1.3
$0.09
(7.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
137.45M
52-Week High
52-Week High
3.23000
52-Week Low
52-Week Low
1.04000
Average Volume
Average Volume
58.45M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization137.45M
icon52-Week High3.23000
icon52-Week Low1.04000
iconAverage Volume58.45M
iconDividend Yield--
iconP/E Ratio--
What does the Cel Sci Corp do?
CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company's Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.
Read More
How much money does Cel Sci Corp make?
News & Events about Cel Sci Corp.
Globe Newswire
3years ago
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CEL-SCI Corporation (CEL-SCI or the Company) (NYSE:CVM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Frequently Asked Questions
Frequently Asked Questions
What is Cel Sci Corp share price today?
plus_minus_icon
Can Indians buy Cel Sci Corp shares?
plus_minus_icon
How can I buy Cel Sci Corp shares from India?
plus_minus_icon
Can Fractional shares of Cel Sci Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Cel Sci Corp stocks?
plus_minus_icon
What is today’s traded volume of Cel Sci Corp?
plus_minus_icon
What is today’s market capitalisation of Cel Sci Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Cel Sci Corp?
plus_minus_icon
What percentage is Cel Sci Corp down from its 52-Week High?
plus_minus_icon
What percentage is Cel Sci Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$1.3
$0.09
(7.54%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$21.09
$0.31 (1.49 %)
Vericel Corporation
Vericel Corporation
$52.33
$0.63 (1.22 %)
Mesoblast
Mesoblast
$7.41
$-0.01 (-0.13 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$6.74
$-0.10 (-1.46 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Kura Oncology Inc
Kura Oncology Inc
$21.09
$0.31 (1.49 %)
Vericel Corporation
Vericel Corporation
$52.33
$0.63 (1.22 %)
Mesoblast
Mesoblast
$7.41
$-0.01 (-0.13 %)
Anavex Life Sciences Corp.
Anavex Life Sciences Corp.
$6.74
$-0.10 (-1.46 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00